Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | AKILI INC | $556,000 | – | 245,912 | – | 13.06% | – | |
| NPCE | Sell | NEUROPACE INC | $161,000 | -86.9% | 42,972 | -82.7% | 3.78% | -78.2% |
| ACCD | Exit | ACCOLADE INC | $0 | – | -58,050 | – | -6.08% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OMIC | New | SINGULAR GENOMICS SYSTEMS INC | $5,409,000 | – | 1,415,846 | – | 76.54% | – |
| NPCE | New | NEUROPACE INC | $1,228,000 | – | 248,127 | – | 17.38% | – |
| ACCD | New | ACCOLADE INC | $430,000 | – | 58,050 | – | 6.08% | – |